Cytokines: Oncostatin M – a new target in IBD?
Nature Reviews Immunology 17, 280 (2017).
doi:10.1038/nri.2017.45
Author: Yvonne Bordon
Oncostatin M promotes intestinal inflammation and can predict responsiveness to anti-TNF therapy in patients with inflammatory bowel diseases.
Source: Nature Reviews Immunology - Category: Allergy & Immunology Authors: Yvonne Bordon Tags: Research Highlight Source Type: research
More News: Allergy & Immunology | Inflammatory Bowel Disease